Wang Guanyi, the actual controller of Inner Mongolia Furui Medical Science (300049.SZ), plans to reduce his holdings by no more than 2.77%.
Furui Medical (300049.SZ) announced that the company's actual controller, Mr. Wang Guanyi, plans to reduce his holdings in the company by no more than 7.3126 million shares (accounting for 2.77% of the company's current total share capital) through centralized bidding and/or block trading within three months after 15 trading days from the date of this announcement.
Inner Mongolia Furui Medical Science (300049.SZ) announced that Mr. Wang Guanyi, the company's actual controller, plans to reduce his shareholding in the company by no more than 7.3126 million shares (accounting for 2.77% of the company's current total share capital) through centralized bidding and/or block trading within three months after the announcement date, starting from the 15th trading day.
Related Articles
KUAISHOU-W (01024) spent HKD 14,991,800 to repurchase 442,000 shares on September 7.
HUNLICAR GROUP (03638): Zhang Lieyun resigns as executive director
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) expands its weight loss drug to younger markets: The STEP Young trial shows that semaglutide significantly reduces obesity rates in children.
KUAISHOU-W (01024) spent HKD 14,991,800 to repurchase 442,000 shares on September 7.
HUNLICAR GROUP (03638): Zhang Lieyun resigns as executive director
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) expands its weight loss drug to younger markets: The STEP Young trial shows that semaglutide significantly reduces obesity rates in children.
RECOMMEND
